Placebo use in clinical practice: Report of the american medical association council on ethical and judicial affairs

Journal of Clinical Ethics

Volumn 19, Issue 1, 2008, Pages 58-61

  Bostick, Nathan A ^a   Sade, Robert ^b   Levine, Mark A ^c   Stewart Jr , Dudley M ^d  

^a AMERICAN MEDICAL ASSOCIATION   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ARTICLE; DOCTOR PATIENT RELATION; ETHICS; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LEGAL ASPECT; MEDICAL SOCIETY; PLACEBO EFFECT; RESEARCH ETHICS; TRUST; UNITED STATES;

AMERICAN MEDICAL ASSOCIATION; ETHICS, RESEARCH; HUMANS; INFORMED CONSENT; PHYSICIAN-PATIENT RELATIONS; PLACEBO EFFECT; PLACEBOS; THERAPEUTIC HUMAN EXPERIMENTATION; TRUST; TRUTH DISCLOSURE; UNITED STATES;

EID: 46449110936     PISSN: 10467890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. H. Brody, "Placebo," in Encyclopedia of Bioethics, ed. W.T. Reich (New York: Simon & Schuster Macmillan, 1995), 1951-3.
2. Ibid.; H. Brody, "The placebo response: Recent research and implications for family medicine," Journal of Family Practice 49, no. 7 (2000): 649-54.
3. A. Hróbjartsson and P.C. Gøtzsche, "An analysis of clinical trials comparing placebo with no treatment," New England Journal of Medicine 344 (2001): 1594-602;
4. J. Glausiusz, "Is the placebo effect a myth?" Discover, 14 September 2001.
5. K. Irizarry and J. Licinio, "An explanation for the placebo effect?" Science 307, no. 5714 (2005): 1411-2.
6. K. Thorns, "The placebo in general practice," Lancet 334 (1994): 1066-7.
7. I. Kleinman, P. Brown, and L. Librach, "Placebo Pain Medication: Ethical and Practical Considerations," Archives of Family Medicine 3 (1994): 453-7.
8. Thorns, see note 6 above; P. Lichtenberg, U. Heresco-Levy, and U. Nitzan, "The ethics of the placebo in clinical practice," Journal of Medical Ethics 30 (2004): 551-4.
9. H. Spiro, "Clinical reflections on the placebo phenomenon," in The Placebo Effect, An Interdisciplinary Exploration, ed. A. Harrington (Cambridge: Harvard University Press, 1997), 37-55.
10. Kleinman, see note 6 above; CEJA Opinion E-10.01, "Fundamental Elements of the Patient-Physician Relationship," www.ama-assn. org/ama1/pub/upload/mm/369/ceja_6a07.pdf
11. Ibid.
12. CEJA, "Fundamental Elements of the Patient-Physician Relationship," see note 9 above.
13. T. Beauchamp and J. Childress, Principles of Biomedical Ethics, 5th ed. (New York: Oxford University Press, 2001).
14. D. Levy, "White doctors and black patients: influence of race on the doctor-patient relationship," Pediatrics 75 (1986): 639-43;
15. A. Kao et al., "The relationship between method of physician payment and patient trust," Journal of the American Medical Association 280 (1998): 1708-14;
16. D. Mechanic, "The functions and limitations of trust in the provision of medical care," Journal of Health Politics, Policy and Law 23 (1998): 661-86.
17. P. Hébert et al., "Bioethics for clinicians: Truth telling," Canadian Medical Association Journal 156 (1997): 225-8.
18. A.J. Barsky et al., "Nonspecific medication side effects and the nocebo phenomenon," Journal of the American Medical Association 287 (2002): 622-7.
19. Thoms, see note 5 above; K. Thomas, "General practice consultations: Is there any point in being positive?" British Medical Journal 294 (1987): 1200-2.
20. Brody, "The Placebo Response," see note 2 above; L. Egbert et al., "Reduction of post-operative pain by encouragement and instruction of patients," New England Journal of Medicine 270 (1964): 825-7.
21. CEJA Opinion E-10.01, "Fundamental Elements of the Patient-Physician Relationship," see note 9 above; CEJA Opinion E-8.08, "In-formed Consent," http://www.ama-assn.org/ apps/pf_new/pf_online?f_n= resultLink&doc =policyfiles/HnE/E-8.08.HTM&s_t= 8.08&catg=AMA/ HnE&catg=AMA/BnGnC&catg =AMA/DIR&&nth=1&&st_p=0&nth= 2&
22. M. Barry, "Involving Patients in Medical Decisions: How Can Physicians Do Better?" Journal of the American Medical Association 282 (1999): 2356-7.
23. Beauchamp and Childress, see note 12 above, pp. 84-6.
24. M. Amanzion and F. Benedetti, "Neuropharmacological dissection of placebo analgesia: expectation activated opioid systems versus conditioning activated specific systems," Journal of Neuroscience 19 (1999): 484-94; L.C. Park and L. Covi, "Non-blind placebo trial: An exploration of neurotic patients' responses to placebo when its inert content is disclosed," Archives of General Psychiatry 12 (1965): 336-45;
25. D. Holmes and D. Bennett, "Experiments to answer questions raised by the use of deception in psychological research: I. Role playing as an alternative to deception. II. Effectiveness of debriefing after a deception. III. Effect of informed consent on deception," Journal of Per-sonality and Social Psychology 29 (1974): 358-67.
26. L. Irwig, P. Glasziou, and L. March, "Ethics of N-of-1 Trials," Lancet 345 (1995): 469.
27. C. Nikles, A. Clavarino, and C. Del Mar, "Using n-of-1 trials as a clinical tool to improve prescribing," British Journal of General Practice 55, no. 512 (2005): 175-80.
28. J.D. Price and J.G. Evance, "N-of-1 randomize controlled trials ('N-of-1 trials') singularly useful in geriatric medicine," Age and Aging 31 (2002): 227-32.
29. Spiro, see note 8 above.
30. Adopted by the American Medical Association House of Delegates November 2006.